371 related articles for article (PubMed ID: 35883640)
1. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond.
Faist A; Janowski J; Kumar S; Hinse S; Çalışkan DM; Lange J; Ludwig S; Brunotte L
Cells; 2022 Jul; 11(14):. PubMed ID: 35883640
[TBL] [Abstract][Full Text] [Related]
2. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.
Low ZY; Zabidi NZ; Yip AJW; Puniyamurti A; Chow VTK; Lal SK
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146796
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
mBio; 2020 May; 11(3):. PubMed ID: 32444382
[TBL] [Abstract][Full Text] [Related]
6. A Game of Infection - Song of Respiratory Viruses and Interferons.
Wang GQ; Gu Y; Wang C; Wang F; Hsu AC
Front Cell Infect Microbiol; 2022; 12():937460. PubMed ID: 35846766
[TBL] [Abstract][Full Text] [Related]
7. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
8. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Boechat JL; Chora I; Morais A; Delgado L
Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
[TBL] [Abstract][Full Text] [Related]
9. Potential role of IFN-α in COVID-19 patients and its underlying treatment options.
Yang L; Wang J; Hui P; Yarovinsky TO; Badeti S; Pham K; Liu C
Appl Microbiol Biotechnol; 2021 May; 105(10):4005-4015. PubMed ID: 33950278
[TBL] [Abstract][Full Text] [Related]
10. COVID-19: imbalanced cell-mediated immune response drives to immunopathology.
Wang J; Li Q; Qiu Y; Lu H
Emerg Microbes Infect; 2022 Dec; 11(1):2393-2404. PubMed ID: 36069182
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses.
Fiorino S; Tateo F; Biase D; Gallo CG; Orlandi PE; Corazza I; Budriesi R; Micucci M; Visani M; Loggi E; Hong W; Pica R; Lari F; Zippi M
Future Microbiol; 2021 Sep; 16(14):1105-1133. PubMed ID: 34468163
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
[TBL] [Abstract][Full Text] [Related]
13. Host Recovery from Respiratory Viral Infection.
Wei X; Narasimhan H; Zhu B; Sun J
Annu Rev Immunol; 2023 Apr; 41():277-300. PubMed ID: 36716750
[TBL] [Abstract][Full Text] [Related]
14. The Pandemic of Coronavirus Disease 2019 (COVID-19).
Rashid NN
Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
Castel AD; Wilbourn B; Magnus M; Greenberg AE
AIDS Rev; 2020; 22(3):133-142. PubMed ID: 33118529
[TBL] [Abstract][Full Text] [Related]
16. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.
Akbarpour M; Sharifi L; Safdarian AR; Farhangnia P; Borjkhani M; Rezaei N
Adv Exp Med Biol; 2021; 1318():149-167. PubMed ID: 33973177
[TBL] [Abstract][Full Text] [Related]
17. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
18. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
[TBL] [Abstract][Full Text] [Related]
19. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated Innate Immune and Inflammatory Responses in SARS-CoV-2 Infection and COVID-19 Severity.
Ghosh P; Nagaraja S; Basavaraju S; Kesavardhana S
Crit Rev Immunol; 2021; 41(3):43-56. PubMed ID: 35378010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
